[vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on November 24, 2020
Dr. Nebojsa Nick Knezevic discusses innovative strategies to target the molecular mechanisms of pain. After reviewing nociceptive and neuropathic pain, inflammatory cytokines, and nociceptor diversity, he introduces pain-related voltage gated ion channels, glial and inflammatory cells, and G-protein-coupled receptor kinase 2 (GRK2). Dr. Knezevic provides compelling evidence that these are promising targets for pain treatment using strategies including monoclonal antibodies, biased μ-opioid receptor ligands, stem cells, and targeted gene therapy.
[/vc_column_text][/vc_column][/vc_row]
Leave a Reply
You must be logged in to post a comment.